Variant report
Variant | esv2320457 |
---|---|
Chromosome Location | chr7:3519830-3520257 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs560083557 | chr7:3519838-3519839 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs117085684 | chr7:3519844-3519845 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs144595226 | chr7:3519852-3519853 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs546716090 | chr7:3519883-3519884 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs10234204 | chr7:3519885-3519886 | Weak transcription Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
6 | rs530784832 | chr7:3519904-3519905 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs190953751 | chr7:3519905-3519906 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs184007203 | chr7:3519907-3519908 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs533448734 | chr7:3519912-3519913 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs547219183 | chr7:3519936-3519937 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs566907568 | chr7:3519949-3519950 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs535555944 | chr7:3519952-3519953 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs555469839 | chr7:3519954-3519955 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs568949099 | chr7:3519970-3519971 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs138773798 | chr7:3520017-3520018 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs557456109 | chr7:3520023-3520024 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs73671843 | chr7:3520024-3520025 | Weak transcription Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs540107264 | chr7:3520034-3520035 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs145496871 | chr7:3520042-3520043 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs560761986 | chr7:3520045-3520046 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs188898686 | chr7:3520055-3520056 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs114394106 | chr7:3520057-3520058 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs561875355 | chr7:3520084-3520085 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs571178033 | chr7:3520089-3520090 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs544635769 | chr7:3520106-3520107 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs532288052 | chr7:3520107-3520108 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs564320786 | chr7:3520123-3520124 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs192399131 | chr7:3520135-3520136 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs546939352 | chr7:3520146-3520147 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs182920330 | chr7:3520154-3520155 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs34542941 | chr7:3520167-3520168 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs560684640 | chr7:3520177-3520178 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs199858841 | chr7:3520191-3520192 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs549580547 | chr7:3520201-3520202 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs187548301 | chr7:3520234-3520235 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Chordoma | 21602918 | CNVD |
Lynch syndrome | 22585707 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Breast cancer | 16397240 | CNVD |
Raine Syndrome | 17924334 | CNVD |
Diffuse large b-cell lymphoma | 21266526 | CNVD |
Melanoma | 18172304 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Glioma | 18556773 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
Developmental delay | 21147756 | CNVD |
Prostate cancer | 18632612 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Nasopharyngeal cancer | 20548289 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
Spondylocostal dysostosis | 21085971 | CNVD |
Mental retardation | 17901693 | CNVD |
Heart disease | 21282601 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Cancer | 20164920 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Intellectual disability | 21811512 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:3491200-3526600 | Weak transcription | Pancreas | Pancrea |
2 | chr7:3502000-3521200 | Weak transcription | Aorta | Aorta |
3 | chr7:3506200-3521000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr7:3512800-3522400 | Weak transcription | H9 Cell Line | embryonic stem cell |
5 | chr7:3513000-3522000 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
6 | chr7:3516000-3521000 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
7 | chr7:3516000-3522200 | Weak transcription | Fetal Lung | lung |
8 | chr7:3516600-3522200 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
9 | chr7:3519800-3520200 | Active TSS | K562 | blood |
10 | chr7:3520000-3520200 | Enhancers | Spleen | Spleen |